current and emerging unmet needs in r/r multiple myeloma: improving qol & novel therapeutic options
Published 1 year ago • 51 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
4:48
unmet needs in unfit/frail patients with multiple myeloma
-
2:05
emerging therapeutic challenges to treating patients with multiple myeloma
-
3:41
emerging therapies for r/r myeloma
-
3:59
addressing the unmet need for patients with lenalidomide-refractory multiple myeloma
-
2:01
the key unmet needs in a post-allosct newly diagnosed myeloma setting
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:23
unmet clinical needs in multiple myeloma
-
5:19
a 17-year fight against multiple myeloma
-
9:59
dr. kessler addresses questions about your hematology appointment
-
9:25
mgus diagnosis: a step-by-step approach
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
1:05
unmet needs in gvhd & the promise of regenerative medicine
-
4:58
novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more
-
2:44
moving car-t into earlier lines of therapy in multiple myeloma
-
1:03
multiple myeloma: what needs to change to improve care?
-
3:05
current status of induction therapy for multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
5:25
novel immunotherapies for multiple myeloma
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
6:38
unmet needs and key challenges in the treatment of all
-
2:41
an overview of the latest advances in hematology